CN
We are developing Genecast THEMIS, our proprietary early screening reagent kit to be used in NGS-based early screening, which detects genetic and epigenetic features including DNA methylation, fragmentomics, and chromosomal abnormality in cfDNA extracted from liquid biopsy samples to provide early screening of breast cancer, CRC, esophageal cancer, liver cancer, lung cancer, pancreatic cancer and gastric cancer.
East Building #20, 20 Xiushui Road, CMC, Taizhou, P.R. China